Digital health startup Locke Bio launches a platform to help direct-to-consumer brands handle pharmaceutical payments. In mid-February, Locke Bio launched Locke Bio Pay, a payment processing ...

"It does not take intelligence to throw money around and buy a company or buy a politician," Seth Abramson writes ...

Bio-Rad Laboratories, Inc. BIO recently entered into a binding agreement to purchase all equity interests in Stilla Technologies ("Stilla"). Stilla’s next-generation digital PCR solutions complement ...

Adicet Bio, Inc. (NASDAQ:ACET), currently trading at $0.99 with a market capitalization of $81.7 million, is a clinical-stage biopharmaceutical company focused on developing novel cell therapies based ...

The veteran performer was a mainstay on TV in the 1980s and 1990s. Trump’s endorsement helped propel Ron DeSantis in the 2018 ...

Bio Asia 2025 will feature high-impact sessions, panel discussions, and networking opportunities, engaging thought leaders, ...

Solid tumors are difficult to treat due to their heterogeneity and limited blood supply, which restrict the effective ...

Global platform for biotech innovation, showcasing start-ups transforming healthcare, fostering collaboration and partnerships.

There is an almost ‘irresistible’ marriage between artificial intelligence (AI) and extended reality (XR), yet while their combination will create benefits, there will also be some downsides.

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be ...

CEO and Founder at UK-based global candidate screening platform Willo ...